1
|
Khwaza V, Mlala S, Aderibigbe BA. Advancements in Synthetic Strategies and Biological Effects of Ciprofloxacin Derivatives: A Review. Int J Mol Sci 2024; 25:4919. [PMID: 38732134 PMCID: PMC11084713 DOI: 10.3390/ijms25094919] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2024] [Revised: 04/25/2024] [Accepted: 04/26/2024] [Indexed: 05/13/2024] Open
Abstract
Ciprofloxacin is a widely used antibiotic in the fluoroquinolone class. It is widely acknowledged by various researchers worldwide, and it has been documented to have a broad range of other pharmacological activities, such as anticancer, antiviral, antimalarial activities, etc. Researchers have been exploring the synthesis of ciprofloxacin derivatives with enhanced biological activities or tailored capability to target specific pathogens. The various biological activities of some of the most potent and promising ciprofloxacin derivatives, as well as the synthetic strategies used to develop them, are thoroughly reviewed in this paper. Modification of ciprofloxacin via 4-oxo-3-carboxylic acid resulted in derivatives with reduced efficacy against bacterial strains. Hybrid molecules containing ciprofloxacin scaffolds displayed promising biological effects. The current review paper provides reported findings on the development of novel ciprofloxacin-based molecules with enhanced potency and intended therapeutic activities which will be of great interest to medicinal chemists.
Collapse
Affiliation(s)
- Vuyolwethu Khwaza
- Department of Chemistry, University of Fort Hare, Alice Campus, Alice 5700, South Africa;
| | | | - Blessing A. Aderibigbe
- Department of Chemistry, University of Fort Hare, Alice Campus, Alice 5700, South Africa;
| |
Collapse
|
2
|
Song M, Hua Y, Liu Y, Xiao X, Yu H, Deng X. Design, Synthesis, and Antimicrobial Activity Evaluation of Ciprofloxacin-Indole Hybrids. Molecules 2023; 28:6325. [PMID: 37687154 PMCID: PMC10488977 DOI: 10.3390/molecules28176325] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2023] [Revised: 08/20/2023] [Accepted: 08/23/2023] [Indexed: 09/10/2023] Open
Abstract
With the overuse and misuse of antimicrobial drugs, antibacterial resistance is becoming a critical global health problem. New antibacterial agents are effective measures for overcoming the crisis of drug resistance. In this paper, a novel set of ciprofloxacin-indole/acetophenone hybrids was designed, synthesized, and structurally elucidated with the help of NMR and high-resolution mass spectrometry. The in vitro antibacterial activities of these hybrids against gram-positive and gram-negative pathogens, including four multidrug-resistant clinical isolates, were evaluated and compared with those of the parent drug ciprofloxacin (CIP). All the target compounds (MIC = 0.0625-32 μg/mL) exhibited excellent inhibitory activity against the strains tested. Among them, 3a (MIC = 0.25-8 μg/mL) showed comparable or slightly less potent activity than CIP. The most active hybrid, 8b (MIC = 0.0626-1 μg/mL), showed equal or higher activity than CIP. Moreover, compound 8b showed superior bactericidal capability to CIP, with undetectably low resistance frequencies. Furthermore, molecular docking studies conducted showed that 8b and CIP had a similar binding mode to DNA gyrase (Staphylocouccus aureus). Thus, hybrids 3a and 8b could act as a platform for further investigations.
Collapse
Affiliation(s)
- Mingxia Song
- Affiliated Hospital of Jinggangshan University, Ji’an 343000, China; (M.S.)
- Health Science Center, Jinggangshan University, Ji’an 343009, China
- Center for Clinical Medicine Research of Jinggangshan University, Jinggangshan University, Ji’an 343009, China
| | - Yi Hua
- Health Science Center, Jinggangshan University, Ji’an 343009, China
- Center for Clinical Medicine Research of Jinggangshan University, Jinggangshan University, Ji’an 343009, China
| | - Yuxin Liu
- Affiliated Hospital of Jinggangshan University, Ji’an 343000, China; (M.S.)
- Center for Clinical Medicine Research of Jinggangshan University, Jinggangshan University, Ji’an 343009, China
| | - Xunli Xiao
- Affiliated Hospital of Jinggangshan University, Ji’an 343000, China; (M.S.)
| | - Haihong Yu
- Health Science Center, Jinggangshan University, Ji’an 343009, China
- Center for Clinical Medicine Research of Jinggangshan University, Jinggangshan University, Ji’an 343009, China
| | - Xianqing Deng
- Affiliated Hospital of Jinggangshan University, Ji’an 343000, China; (M.S.)
- Health Science Center, Jinggangshan University, Ji’an 343009, China
- Center for Clinical Medicine Research of Jinggangshan University, Jinggangshan University, Ji’an 343009, China
| |
Collapse
|
3
|
Struga M, Roszkowski P, Bielenica A, Otto-Ślusarczyk D, Stępień K, Stefańska J, Zabost A, Augustynowicz-Kopeć E, Koliński M, Kmiecik S, Myslovska A, Wrzosek M. N-Acylated Ciprofloxacin Derivatives: Synthesis and In Vitro Biological Evaluation as Antibacterial and Anticancer Agents. ACS OMEGA 2023; 8:18663-18684. [PMID: 37273589 PMCID: PMC10233829 DOI: 10.1021/acsomega.3c00554] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 01/27/2023] [Accepted: 05/09/2023] [Indexed: 06/06/2023]
Abstract
A novel series of N-acylated ciprofloxacin (CP) conjugates 1-21 were synthesized and screened as potential antimicrobial agents. Conjugates 1 and 2 were 1.25-10-fold more potent than CP toward all Staphylococci (minimal inhibitory concentration 0.05-0.4 μg/mL). Most of the chloro- (3-7), bromo- (8-11), and CF3-alkanoyl (14-16) derivatives expressed higher or comparable activity to CP against selected Gram-positive strains. A few CP analogues (5, 10, and 11) were also more effective toward the chosen clinical Gram-negative rods. Conjugates 5, 10, and 11 considerably influenced the phases of the bacterial growth cycle over 18 h. Additionally, compounds 2, 4-7, 9-12, and 21 exerted stronger tuberculostatic action against three Mycobacterium tuberculosis isolates than the first-line antitubercular drugs. Amides 1, 2, 5, 6, 10, and 11 targeted gyrase and topoisomerase IV at 2.7-10.0 μg/mL, which suggests a mechanism of antibacterial action related to CP. These findings were confirmed by molecular docking studies. In addition, compounds 3 and 15 showed high antiproliferative activities against prostate PC3 cells (IC50 2.02-4.8 μM), up to 6.5-2.75 stronger than cisplatin. They almost completely reduced the growth and proliferation rates in these cells, without a cytotoxic action against normal HaCaT cell lines. Furthermore, derivatives 3 and 21 induced apoptosis/necrosis in PC3 cells, probably by increasing the intracellular ROS amount, as well as they diminished the IL-6 level in tumor cells.
Collapse
Affiliation(s)
- Marta Struga
- Chair
and Department of Biochemistry, Medical
University of Warsaw, ul. Banacha 1, 02-097 Warsaw, Poland
| | - Piotr Roszkowski
- Faculty
of Chemistry, University of Warsaw, Pasteura 1, 02-093 Warsaw, Poland
| | - Anna Bielenica
- Chair
and Department of Biochemistry, Medical
University of Warsaw, ul. Banacha 1, 02-097 Warsaw, Poland
| | - Dagmara Otto-Ślusarczyk
- Chair
and Department of Biochemistry, Medical
University of Warsaw, ul. Banacha 1, 02-097 Warsaw, Poland
| | - Karolina Stępień
- Department
of Pharmaceutical Microbiology, Centre for Preclinical Research, Medical University of Warsaw, 02-097 Warsaw, Poland
| | - Joanna Stefańska
- Department
of Pharmaceutical Microbiology, Centre for Preclinical Research, Medical University of Warsaw, 02-097 Warsaw, Poland
| | - Anna Zabost
- Department
of Microbiology, National Tuberculosis and
Lung Diseases Research Institute, 01-138 Warsaw, Poland
| | - Ewa Augustynowicz-Kopeć
- Department
of Microbiology, National Tuberculosis and
Lung Diseases Research Institute, 01-138 Warsaw, Poland
| | - Michał Koliński
- Bioinformatics
Laboratory, Mossakowski Medical Research Institute, Polish Academy of Sciences, 5 Pawinskiego Street, 02-106 Warsaw, Poland
| | - Sebastian Kmiecik
- Biological
and Chemical Research Centre, Faculty of Chemistry, University of Warsaw, 02-089 Warsaw, Poland
| | - Alina Myslovska
- Faculty
of Chemistry, University of Warsaw, Pasteura 1, 02-093 Warsaw, Poland
| | - Małgorzata Wrzosek
- Department
of Biochemistry and Pharmacogenomics, Faculty of Pharmacy, Medical University of Warsaw, 02-097 Warsaw, Poland
| |
Collapse
|
4
|
Gao J, Hou H, Gao F. Current scenario of quinolone hybrids with potential antibacterial activity against ESKAPE pathogens. Eur J Med Chem 2023; 247:115026. [PMID: 36577217 DOI: 10.1016/j.ejmech.2022.115026] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2022] [Revised: 12/04/2022] [Accepted: 12/13/2022] [Indexed: 12/24/2022]
Abstract
The ESKAPE (Escherichia coli/E. coli, Staphylococcus aureus/S. aureus, Klebsiella pneumonia/K. pneumoniae, Acinetobacter Baumannii/A. baumannii, Pseudomonas aeroginosa/P. aeroginosa and Enterobacter spp.) pathogens, which could escape or evade common therapies through diverse antimicrobial resistance mechanisms and biofilm formation, are deemed as highly virulent bacteria responsible for life-threatening diseases, calling for novel chemotherapeutics. Quinolones including 2-quinolones and 4-quinolones have occupied a propitious place in drug design and development due to their excellent pharmacological profiles. Quinolones especially fluoroquinolones could inhibit the synthesis of nucleic acid of ESKAPE pathogens, leading to the rupture of bacterial chromosome. However, the resistance of ESKAPE pathogens to quinolones develops rapidly and spreads widely. Accordingly, it has become increasingly urgent to enhance the potency of quinolones against both drug-susceptible and drug-resistant ESKAPE pathogens. Quinolone hybrids can bind with different drug targets simultaneously and have been considered as useful prototypes to circumvent drug resistance. The purpose of this review is to summarize the current scenario (2018-present) of quinolone hybrids with potential antibacterial activity against ESKAPE pathogens, together with the structure-activity relationships and mechanisms of action to facilitate further rational design of more effective candidates.
Collapse
Affiliation(s)
- Jingyue Gao
- Key Laboratory for Experimental Teratology of the Ministry of Education and Center for Experimental Nuclear Medicine, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, China
| | - Haodong Hou
- Key Laboratory for Experimental Teratology of the Ministry of Education and Center for Experimental Nuclear Medicine, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, China
| | - Feng Gao
- Key Laboratory for Experimental Teratology of the Ministry of Education and Center for Experimental Nuclear Medicine, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, China.
| |
Collapse
|
5
|
Abdel-Aziz SA, Cirnski K, Herrmann J, Abdel-Aal MA, Youssif B, Salem O. Novel fluoroquinolone hybrids as dual DNA gyrase and urease inhibitors with potential antibacterial activity: Design, synthesis, and biological evaluation. J Mol Struct 2022. [DOI: 10.1016/j.molstruc.2022.134049] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
6
|
Design and synthesis of new N-thioacylated ciprofloxacin derivatives as urease inhibitors with potential antibacterial activity. Sci Rep 2022; 12:13827. [PMID: 35970866 PMCID: PMC9378659 DOI: 10.1038/s41598-022-17993-4] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2022] [Accepted: 08/03/2022] [Indexed: 01/06/2023] Open
Abstract
A new series of N-thioacylated ciprofloxacin 3a-n were designed and synthesized based on Willgerodt-Kindler reaction. The results of in vitro urease inhibitory assay indicated that almost all the synthesized compounds 3a-n (IC50 = 2.05 ± 0.03-32.49 ± 0.32 μM) were more potent than standard inhibitors, hydroxyurea (IC50 = 100 ± 2.5 μM) and thiourea (IC50 = 23 ± 0.84 μM). The study of antibacterial activity against Gram-positive species (S. aureus and S. epidermidis) revealed that the majority of compounds were more active than ciprofloxacin as the standard drug, and 3h derivative bearing 3-fluoro group had the same effect as ciprofloxacin against Gram-negative bacteria (P. aeruginosa and E. coli). Based on molecular dynamic simulations, compound 3n exhibited pronounced interactions with the critical residues of the urease active site and mobile flap pocket so that the quinolone ring coordinated toward the metal bi-nickel center and the essential residues at the flap site like His593, His594, and Arg609. These interactions caused blocking the active site and stabilized the movement of the mobile flap at the entrance of the active site channel, which significantly reduced the catalytic activity of urease. Noteworthy, 3n also exhibited IC50 values of 5.59 ± 2.38 and 5.72 ± 1.312 µg/ml to inhibit urease enzyme against C. neoformans and P. vulgaris in the ureolytic assay.
Collapse
|
7
|
Li FF, Zhao WH, Tangadanchu VKR, Meng JP, Zhou CH. Discovery of novel phenylhydrazone-based oxindole-thiolazoles as potent antibacterial agents toward Pseudomonas aeruginosa. Eur J Med Chem 2022; 239:114521. [PMID: 35716514 DOI: 10.1016/j.ejmech.2022.114521] [Citation(s) in RCA: 29] [Impact Index Per Article: 14.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2022] [Revised: 06/01/2022] [Accepted: 06/04/2022] [Indexed: 11/24/2022]
Abstract
With the soaring of bacterial infection and drug resistance, it is imperative to exploit new efficient antibacterial agents. This work constructed a series of unique phenylhydrazone-based oxindole-thiolazoles to combat monstrous bacterial resistance. Some target molecules showed potent antibacterial activity, among which oxindole-thiolimidazole derived carboxyphenylhydrazone 4e exhibited an 8-fold stronger inhibitory ability than norfloxacin on the growth of P. aeruginosa, with MIC value of 1 μg/mL. Compound 4e with imperceptible hemolysis could hamper bacterial biofilm formation and significantly impede the development of bacterial resistance. Subsequent mechanism studies demonstrated that 4e could destruct bacterial cytoplasmic membrane, causing the leakage of cellular contents (protein and nucleic acid). Moreover, metabolic stagnation and intracellular oxidative stress caused by 4e expedited the death of bacteria. Furthermore, molecule 4e existed supramolecular interactions with DNA to block DNA proliferation. These research results provided a promising light for phenylhydrazone-based oxindole-thiolazoles as novel potential antibacterial agents.
Collapse
Affiliation(s)
- Fen-Fen Li
- Institute of Bioorganic & Medicinal Chemistry, Key Laboratory of Applied Chemistry of Chongqing Municipality, School of Chemistry and Chemical Engineering, Southwest University, Chongqing, 400715, China
| | - Wen-Hao Zhao
- Institute of Bioorganic & Medicinal Chemistry, Key Laboratory of Applied Chemistry of Chongqing Municipality, School of Chemistry and Chemical Engineering, Southwest University, Chongqing, 400715, China
| | - Vijai Kumar Reddy Tangadanchu
- Institute of Bioorganic & Medicinal Chemistry, Key Laboratory of Applied Chemistry of Chongqing Municipality, School of Chemistry and Chemical Engineering, Southwest University, Chongqing, 400715, China
| | - Jiang-Ping Meng
- College of Pharmacy, National & Local Joint Engineering Research Center of Targeted and Innovative Therapeutics, Chongqing Key Laboratory of Kinase Modulators As Innovative Medicine, Chongqing University of Arts and Sciences, Chongqing, 402160, China.
| | - Cheng-He Zhou
- Institute of Bioorganic & Medicinal Chemistry, Key Laboratory of Applied Chemistry of Chongqing Municipality, School of Chemistry and Chemical Engineering, Southwest University, Chongqing, 400715, China.
| |
Collapse
|
8
|
Saadon KE, Taha NMH, Mahmoud NA, Elhagali GAM, Ragab A. Synthesis, characterization, and in vitro antibacterial activity of some new pyridinone and pyrazole derivatives with some in silico ADME and molecular modeling study. JOURNAL OF THE IRANIAN CHEMICAL SOCIETY 2022. [DOI: 10.1007/s13738-022-02575-y] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
AbstractA new series of pyridine-2-one and pyrazole derivatives were designed and synthesized based on cyanoacrylamide derivatives containing 2,4-dichlro aniline and 6-methyl 2-amino pyridine as an aryl group. Condensation of cyanoacrylamide derivatives 3a–d with different active methylene (malononitrile, ethyl cyanoacetate cyanoacetamide, and ethyl acetoacetate) in the presence of piperidine as basic catalyst afforded the corresponding pyridinone derivatives 4a–c, 5, 9, and 13. Furthermore, the reaction of cyanoacrylamide derivatives 3a–d with bi-nucleophile as hydrazine hydrate and thiosemicarbazide afforded the corresponding pyrazole derivatives 14a,b and 16. The newly designed derivatives were confirmed and established based on the elemental analysis and spectra data (IR, 1H NMR, 13C NMR, and mass). The in vitro antibacterial activity was evaluated against four bacterial strains with weak to good antibacterial activity. Moreover, the results indicated that the most active derivatives 3a, 4a, 4b, 9, and 16 might lead to antibacterial agents, especially against B. subtilis and P. vulgaris. The DFT calculations were performed to estimate its geometric structure and electronic properties. In addition, the most active pyridinone and pyrazole derivatives were further evaluated for in silico physicochemical, drug-likeness, and toxicity prediction. These derivatives obeyed all Lipinski’s and Veber’s rules without any violation and displayed non-immunotoxin, non-mutagenic, and non-cytotoxic. Molecular docking simulation was performed inside the active site of Topoisomerase IV (PDB:3FV5). It displayed binding energy ranging from -14.97 kcal/mol to -18.86 kcal/mol with hydrogen bonding and arene–cation interaction. Therefore, these derivatives were suggested to be good antibacterial agents via topoisomerase IV inhibitor.
Graphical abstract
Collapse
|
9
|
Novel metronidazole-derived three-component hybrids as promising broad-spectrum agents to combat oppressive bacterial resistance. Bioorg Chem 2022; 122:105718. [DOI: 10.1016/j.bioorg.2022.105718] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2021] [Revised: 01/21/2022] [Accepted: 03/01/2022] [Indexed: 12/11/2022]
|
10
|
Zang W, Li D, Gao L, Gao S, Hao P, Bian H. The antibacterial potential of ciprofloxacin hybrids against Staphylococcus aureus. Curr Top Med Chem 2022; 22:1020-1034. [PMID: 35301951 DOI: 10.2174/1568026622666220317162132] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2021] [Revised: 02/01/2022] [Accepted: 02/13/2022] [Indexed: 11/22/2022]
Abstract
Staphylococcus aureus (S. aureus), an important pathogen of both humans and animals, is able to cause a variety of infections at any site of the body. The evolution of S. aureus resistance is notorious, and the widespread of drug-resistant S. aureus, especially methicillin-resistant S. aureus (MRSA), has made the treatment difficult in recent decades. Nowadays, S. aureus is among the leading causes of bacterial infections, creating an urgent need for the development of novel antibacterial agents. Ciprofloxacin, characterized by high clinical efficacy, is a broad-spectrum antibacterial agent with frequency of prescription for various Gram-positive and Gram-negative pathogens, many of which are resistant to a wide range of antibiotics. However, the long-term and widespread use of this antibiotic has led to the emergence of ciprofloxacin-resistant pathogens, and ciprofloxacin-resistant S. aureus has been noted in clinical practice. Ciprofloxacin hybrids have been recognized as advanced chemical entities to simultaneously modulate multiple drug targets in bacteria, so ciprofloxacin hybrids have the potential to overcome drug resistance. The present review provides an overview of ciprofloxacin hybrids with anti-S. aureus potential that have been reported in the last decade with emphasis on their structure-activity relationships and mechanisms of action.
Collapse
Affiliation(s)
- Wenhua Zang
- Zhang Zhongjing College of Traditional Chinese Medicine, Nanyang Institute of Technology, Nanyang 473004, Henan, China;
- Henan Key Laboratory of Zhang Zhongjing Formulae and Herbs for Immunoregulation, Nanyang 473004, Henan, China
| | - Danxia Li
- Zhang Zhongjing College of Traditional Chinese Medicine, Nanyang Institute of Technology, Nanyang 473004, Henan, China;
- Henan Key Laboratory of Zhang Zhongjing Formulae and Herbs for Immunoregulation, Nanyang 473004, Henan, China
| | - Li Gao
- Zhang Zhongjing College of Traditional Chinese Medicine, Nanyang Institute of Technology, Nanyang 473004, Henan, China;
- Henan Key Laboratory of Zhang Zhongjing Formulae and Herbs for Immunoregulation, Nanyang 473004, Henan, China
| | - Shuang Gao
- Zhang Zhongjing College of Traditional Chinese Medicine, Nanyang Institute of Technology, Nanyang 473004, Henan, China;
- Henan Key Laboratory of Zhang Zhongjing Formulae and Herbs for Immunoregulation, Nanyang 473004, Henan, China
| | - Pengfei Hao
- Zhang Zhongjing College of Traditional Chinese Medicine, Nanyang Institute of Technology, Nanyang 473004, Henan, China;
- Henan Key Laboratory of Zhang Zhongjing Formulae and Herbs for Immunoregulation, Nanyang 473004, Henan, China
| | - Hua Bian
- Zhang Zhongjing College of Traditional Chinese Medicine, Nanyang Institute of Technology, Nanyang 473004, Henan, China;
- Henan Key Laboratory of Zhang Zhongjing Formulae and Herbs for Immunoregulation, Nanyang 473004, Henan, China
| |
Collapse
|
11
|
Cheke RS, Patil VM, Firke SD, Ambhore JP, Ansari IA, Patel HM, Shinde SD, Pasupuleti VR, Hassan MI, Adnan M, Kadri A, Snoussi M. Therapeutic Outcomes of Isatin and Its Derivatives against Multiple Diseases: Recent Developments in Drug Discovery. Pharmaceuticals (Basel) 2022; 15:ph15030272. [PMID: 35337070 PMCID: PMC8950263 DOI: 10.3390/ph15030272] [Citation(s) in RCA: 30] [Impact Index Per Article: 15.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2021] [Revised: 01/29/2022] [Accepted: 01/30/2022] [Indexed: 12/22/2022] Open
Abstract
Isatin (1H indole 2, 3-dione) is a heterocyclic, endogenous lead molecule recognized in humans and different plants. The isatin nucleus and its derivatives are owed the attention of researchers due to their diverse pharmacological activities such as anticancer, anti-TB, antifungal, antimicrobial, antioxidant, anti-inflammatory, anticonvulsant, anti-HIV, and so on. Many research chemists take advantage of the gentle structure of isatins, such as NH at position 1 and carbonyl functions at positions 2 and 3, for designing biologically active analogues via different approaches. Literature surveys based on reported preclinical, clinical, and patented details confirm the multitarget profile of isatin analogues and thus their importance in the field of medicinal chemistry as a potent chemotherapeutic agent. This review represents the recent development of isatin analogues possessing potential pharmacological action in the years 2016–2020. The structure–activity relationship is also discussed to provide a pharmacophoric pattern that may contribute in the future to the design and synthesis of potent and less toxic therapeutics.
Collapse
Affiliation(s)
- Rameshwar S. Cheke
- Department of Pharmaceutical Chemistry, Dr. Rajendra Gode College of Pharmacy, Malkapur 443101, Maharashtra, India;
- Correspondence: (R.S.C.); (V.R.P.)
| | - Vaishali M. Patil
- Department of Pharmaceutical Chemistry, KIET School of Pharmacy, KIET Group of Institutions, Delhi-NCR, Ghaziabad 201206, Uttar Pradesh, India;
| | - Sandip D. Firke
- Department of Pharmaceutical Chemistry, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur 425405, Maharashtra, India; (S.D.F.); (I.A.A.); (H.M.P.)
| | - Jaya P. Ambhore
- Department of Pharmaceutical Chemistry, Dr. Rajendra Gode College of Pharmacy, Malkapur 443101, Maharashtra, India;
| | - Iqrar A. Ansari
- Department of Pharmaceutical Chemistry, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur 425405, Maharashtra, India; (S.D.F.); (I.A.A.); (H.M.P.)
| | - Harun M. Patel
- Department of Pharmaceutical Chemistry, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur 425405, Maharashtra, India; (S.D.F.); (I.A.A.); (H.M.P.)
| | - Sachin D. Shinde
- Department of Pharmacology, Shri. R. D. Bhakt College of Pharmacy, Jalna 431213, Maharashtra, India;
| | - Visweswara Rao Pasupuleti
- Department of Biomedical Sciences and Therapeutics, Faculty of Medicine & Health Sciences, University Malaysia Sabah, Kota Kinabalu 44800, Sabah, Malaysia
- Department of Biochemistry, Faculty of Medicine and Health Sciences, Abdurrab University, Pekanbaru 28291, Riau, Indonesia
- Centre for International Collaboration and Research, Reva University, Rukmini Knowledge Park, Kattigenahalli, Yelahanka, Bangalore 560064, Karnataka, India
- Correspondence: (R.S.C.); (V.R.P.)
| | - Md Imtaiyaz Hassan
- Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, Jamia Nagar, New Delhi 110025, India;
| | - Mohd Adnan
- Department of Biology, College of Science, University of Hail, Hail P.O. Box 2440, Ha′il 2440, Saudi Arabia; (M.A.); (M.S.)
| | - Adel Kadri
- Faculty of Science of Sfax, Department of Chemistry, University of Sfax, B.P. 1171, Sfax 3000, Tunisia;
- Faculty of Science and Arts in Baljurashi, Albaha University, P.O. Box 1988, Albaha 65527, Saudi Arabia
| | - Mejdi Snoussi
- Department of Biology, College of Science, University of Hail, Hail P.O. Box 2440, Ha′il 2440, Saudi Arabia; (M.A.); (M.S.)
- Laboratory of Genetics, Biodiversity and Valorization of Bio-Resources (LR11ES41), University of Monastir, Higher Institute of Biotechnology of Monastir, Avenue Tahar Haddad, BP74, Monastir 5000, Tunisia
| |
Collapse
|
12
|
Synthesis, in vitro antimicrobial evaluation, and molecular docking studies of new isatin-1,2,3-triazole hybrids. J Mol Struct 2022. [DOI: 10.1016/j.molstruc.2021.131855] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
|
13
|
Elsayed ZM, Eldehna WM, Abdel-Aziz MM, El Hassab MA, Elkaeed EB, Al-Warhi T, Abdel-Aziz HA, Abou-Seri SM, Mohammed ER. Development of novel isatin-nicotinohydrazide hybrids with potent activity against susceptible/resistant Mycobacterium tuberculosis and bronchitis causing-bacteria. J Enzyme Inhib Med Chem 2021; 36:384-393. [PMID: 33406941 PMCID: PMC7801109 DOI: 10.1080/14756366.2020.1868450] [Citation(s) in RCA: 24] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2020] [Revised: 12/11/2020] [Accepted: 12/17/2020] [Indexed: 01/19/2023] Open
Abstract
Joining the global fight against Tuberculosis, the world's most deadly infectious disease, herein we present the design and synthesis of novel isatin-nicotinohydrazide hybrids (5a-m and 9a-c) as promising anti-tubercular and antibacterial agents. The anti-tubercular activity of the target hybrids was evaluated against drug-susceptible M. tuberculosis strain (ATCC 27294) where hybrids 5d, 5g and 5h were found to be as potent as INH with MIC = 0.24 µg/mL, also the activity was evaluated against Isoniazid/Streptomycin resistant M. tuberculosis (ATCC 35823) where compounds 5g and 5h showed excellent activity (MIC = 3.9 µg/mL). Moreover, the target hybrids were examined against six bronchitis causing-bacteria. Most derivatives exhibited excellent antibacterial activity. K. pneumonia emerged as the most sensitive strain with MIC range: 0.49-7.81 µg/mL. Furthermore, a molecular docking study has proposed DprE1 as a probable enzymatic target for herein reported isatin-nicotinohydrazide hybrids, and explored the binding interactions within the vicinity of DprE1 active site.
Collapse
Affiliation(s)
- Zainab M. Elsayed
- Faculty of Pharmacy, Scientific Research and Innovation Support Unit, Kafrelsheikh University, Kafrelsheikh, Egypt
| | - Wagdy M. Eldehna
- Faculty of Pharmacy, Scientific Research and Innovation Support Unit, Kafrelsheikh University, Kafrelsheikh, Egypt
- Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Kafrelsheikh University, Kafrelsheikh, Egypt
| | - Marwa M. Abdel-Aziz
- The Regional Center for Mycology & Biotechnology, Al-Azhar University, Cairo, Egypt
| | - Mahmoud A. El Hassab
- Department of Pharmaceutical Chemistry, School of Pharmacy, Badr University in Cairo, Badr City, Egypt
| | - Eslam B. Elkaeed
- Department of Pharmaceutical Sciences, College of Pharmacy, AlMaarefa University, Ad Diriyah, Saudi Arabia
- Faculty of Pharmacy (Boys), Department of Pharmaceutical Organic Chemistry, Al-Azhar University, Cairo, Egypt
| | - Tarfah Al-Warhi
- Department of Chemistry, College of Science, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia
| | - Hatem A. Abdel-Aziz
- Department of Applied Organic Chemistry, National Research Center, Giza, Egypt
| | - Sahar M. Abou-Seri
- Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Cairo University, Cairo, Egypt
| | - Eman R. Mohammed
- Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Cairo University, Cairo, Egypt
| |
Collapse
|
14
|
One-pot strategy for thiazole tethered 7-ethoxy quinoline hybrids: Synthesis and potential antimicrobial agents as dihydrofolate reductase (DHFR) inhibitors with molecular docking study. J Mol Struct 2021. [DOI: 10.1016/j.molstruc.2021.130748] [Citation(s) in RCA: 21] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
|
15
|
Joshi S, Yadav D, Yadav R. Fluoroquinolones: a review on anti-tubercular activity. MONATSHEFTE FUR CHEMIE 2021. [DOI: 10.1007/s00706-021-02806-7] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
16
|
Varpe BD, Kulkarni AA, Jadhav SB, Mali AS, Jadhav SY. Isatin Hybrids and Their Pharmacological Investigations. Mini Rev Med Chem 2021; 21:1182-1225. [PMID: 33302835 DOI: 10.2174/1389557520999201209213029] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2020] [Revised: 09/01/2020] [Accepted: 10/16/2020] [Indexed: 11/22/2022]
Abstract
Hybridization is an important strategy to design molecules that can be effectively used to treat fatal diseases known to mankind. Molecular hybrids and their pharmacological investigations aided in discovering several potent isatin (Indole 2, 3 dione) derivatives with anti-HIV, antimalarial, antitubercular, antibacterial, and anticancer activities. Indole-2,3-dione and their derivatives have diverse pharmacological properties and have a prominent role in the discovery of new drugs. To understand the various approaches for designing new molecules based on isatin nucleus analysis of various pharmacophore hybrids, spacers/linkers between pharmacophores and isatin for hybridization and their biological activities are important. This review discusses the progress in developing isatin hybrids as biologically effective agents and their crucial aspects of design and structure-activity relationships.
Collapse
Affiliation(s)
- Bhushan D Varpe
- Department of Pharmaceutical Chemistry, DKSS's Institute of Pharmaceutical Science and Research, Swami Chincholi, Dist-Pune, 413130 Maharashtra, India
| | - Amol A Kulkarni
- Department of Pharmaceutical Chemistry, DKSS's Institute of Pharmaceutical Science and Research, Swami Chincholi, Dist-Pune, 413130 Maharashtra, India
| | - Shailaja B Jadhav
- PES's Modern College of Pharmacy, Nigdi, Pune, 411044, Maharashtra, India
| | - Anil S Mali
- Department of Pharmaceutical Chemistry, DKSS's Institute of Pharmaceutical Science and Research, Swami Chincholi, Dist-Pune, 413130 Maharashtra, India
| | - Shravan Y Jadhav
- Department of Chemistry, DBF Dayanand College of Arts & Science, Solapur 413002, Maharashtra, India
| |
Collapse
|
17
|
Jia Y, Zhao L. The antibacterial activity of fluoroquinolone derivatives: An update (2018-2021). Eur J Med Chem 2021; 224:113741. [PMID: 34365130 DOI: 10.1016/j.ejmech.2021.113741] [Citation(s) in RCA: 30] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2021] [Accepted: 08/02/2021] [Indexed: 12/20/2022]
Abstract
Bacterial infection is amongst the most common diseases in community and hospital settings. Fluoroquinolones, exerting the antibacterial activity through binding to type II bacterial topoisomerase enzymes, DNA gyrase and topoisomerase IV, are mainstays of chemotherapy. At present, fluoroquinolones are the most valuable antibacterial agents used popularly. However, the emergence of more virulent and resistant pathogens by the development of either mutated DNA-binding proteins or efflux pump mechanism for fluoroquinolones results in an urgent demand to develop new fluoroquinolones to withstand the drug resistance and to obtain a broader spectrum of activity. This review aims to outline the recent advances of fluoroquinolone derivatives with antibacterial potential and to summarize the structure-activity relationship (SAR) so as to provide an insight for rational design of more active candidates, covering articles published between January 2018 and June 2021.
Collapse
Affiliation(s)
- Yanshu Jia
- Faculty of Science and Technology, Quest International University Perak, Ipoh, 30250, Perak, Malaysia
| | - Liyan Zhao
- Department of Paediatrics, Zhuji Affiliated Hospital of Shaoxing University, Shaoxing, China.
| |
Collapse
|
18
|
Tangadanchu VKR, Sui YF, Zhou CH. Isatin-derived azoles as new potential antimicrobial agents: Design, synthesis and biological evaluation. Bioorg Med Chem Lett 2021; 41:128030. [PMID: 33839249 DOI: 10.1016/j.bmcl.2021.128030] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2021] [Revised: 04/03/2021] [Accepted: 04/05/2021] [Indexed: 12/18/2022]
Abstract
Novel antibiotics are forced to be developed on account of multidrug-resistant bacteria with serious threats to human health. This work developed isatin-derived azoles as new potential antimicrobial agents. Bioactive assay revealed that isatin hybridized 1,2,4-triazole 7a exhibited excellent inhibitory activity against E. coli ATCC 25,922 with an MIC value of 1 µg/mL, which was 8-fold more potent than reference drug norfloxacin. The active molecule 7a possessed the ability to kill some bacteria and fungi as well as displayed low propensity to induce resistance towards E. coli ATCC25922. Preliminary mechanism investigation indicated that hybrid 7a might block deoxyribonucleic acid (DNA) replication by intercalating with DNA and possibly interacting with DNA polymerase III, thus exerting its antimicrobial potency.
Collapse
Affiliation(s)
- Vijai Kumar Reddy Tangadanchu
- Institute of Bioorganic & Medicinal Chemistry, Key Laboratory of Luminescence Analysis and Molecular Sensing, Ministry of Education, School of Chemistry and Chemical Engineering, Southwest University, Chongqing 400715, PR China
| | - Yan-Fei Sui
- Institute of Bioorganic & Medicinal Chemistry, Key Laboratory of Luminescence Analysis and Molecular Sensing, Ministry of Education, School of Chemistry and Chemical Engineering, Southwest University, Chongqing 400715, PR China
| | - Cheng-He Zhou
- Institute of Bioorganic & Medicinal Chemistry, Key Laboratory of Luminescence Analysis and Molecular Sensing, Ministry of Education, School of Chemistry and Chemical Engineering, Southwest University, Chongqing 400715, PR China.
| |
Collapse
|
19
|
Kumar R, Takkar P. Repositioning of Isatin hybrids as novel anti-tubercular agents overcoming pre-existing antibiotics resistance. Med Chem Res 2021. [DOI: 10.1007/s00044-021-02699-5] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
|
20
|
Chauhan G, Pathak DP, Ali F, Bhutani R, Kapoor G, Khasimbi S. Advances in Synthesis, Derivatization and Bioactivity of Isatin: A Review. Curr Org Synth 2021; 18:37-74. [DOI: 10.2174/1570179417666200924150907] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2020] [Revised: 08/24/2020] [Accepted: 08/31/2020] [Indexed: 01/03/2023]
Abstract
Background:
Isatin (IST) is a crucial pharmacologically active compound, chemically known as indole-
1H-2,3-dione. Development of different IST based analogues acquired significant awareness because of its
pronounced therapeutic importance such as analgesic, anticancer, anti-inflammatory, antitubercular, antimicrobial,
antifungal, antiviral (effective against SARS coronavirus 3C protease) and many other activities, and represents
an important class of heterocyclic compounds that can be used as a precursor for the synthesis of many useful
drugs.
Objective:
Previously, many articles were reported on IST synthesis and its different pharmacological activities
but herein, we mentioned 59 different synthesis schemes of several IST derivatives/hybrids derived from the substitution
of the nitrogen, aromatic ring, the second and third position of IST along with most potent molecule
among each of synthesized libraries with their structural activity relationship (SAR). Using these standardized
approaches, several biologically important compounds were developed like sunitinib, nintedanib, indirubin, etc
and several studies have been carried out nowadays to develop newer compounds having fewer side effects and
also overcome the problem of resistance.
Conclusion:
This report critically reviews the different strategies for the designs and synthesis of several IST
based compounds having different biological activities with SAR, which can favour further investigation and
modification for the development of new and more potent entities.
Collapse
Affiliation(s)
- Garima Chauhan
- Department of Pharmaceutical Chemistry, Delhi Institute of Pharmaceutical Science and Research (DIPSAR),Mehrauli-Badarpur Road, Sector 3, Pushp Vihar, New Delhi, India
| | - Dharam Pal Pathak
- Department of Pharmaceutical Chemistry, Delhi Institute of Pharmaceutical Science and Research (DIPSAR),Mehrauli-Badarpur Road, Sector 3, Pushp Vihar, New Delhi, India
| | - Faraat Ali
- Department of Pharmaceutical Chemistry, Delhi Institute of Pharmaceutical Science and Research (DIPSAR),Mehrauli-Badarpur Road, Sector 3, Pushp Vihar, New Delhi, India
| | - Rubina Bhutani
- School of Medical and Allied Sciences, G D Goenka University, Gurugram, Sohna, Haryana, India
| | - Garima Kapoor
- KIET Group of Institutions, Ghaziabad- Meerut Highway, NH-58, Ghaziabad, Uttar Pradesh, India
| | - Shaik Khasimbi
- Department of Pharmaceutical Chemistry, Delhi Institute of Pharmaceutical Science and Research (DIPSAR),Mehrauli-Badarpur Road, Sector 3, Pushp Vihar, New Delhi, India
| |
Collapse
|
21
|
Isatin containing heterocycles for different biological activities: Analysis of structure activity relationship. J Mol Struct 2020. [DOI: 10.1016/j.molstruc.2020.128900] [Citation(s) in RCA: 23] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
|
22
|
Meng T, Hou Y, Shang C, Zhang J, Zhang B. Recent advances in indole dimers and hybrids with antibacterial activity against methicillin-resistant Staphylococcus aureus. Arch Pharm (Weinheim) 2020; 354:e2000266. [PMID: 32986279 DOI: 10.1002/ardp.202000266] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2020] [Revised: 08/30/2020] [Accepted: 09/05/2020] [Indexed: 01/27/2023]
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA), one of the major and most dangerous pathogens in humans, is a causative agent of severe pandemic of mainly skin and soft tissue and occasionally fatal infections. Therefore, it is imperative to develop potent and novel anti-MRSA agents. Indole derivatives could act against diverse enzymes and receptors in bacteria, occupying a salient place in the development of novel antibacterial agents. Dimerization and hybridization are common strategies to discover new drugs, and a number of indole dimers and hybrids possess potential antibacterial activity against a panel of clinically important pathogens including MRSA. Accordingly, indole dimers and hybrids are privileged scaffolds for the discovery of novel anti-MRSA agents. This review outlines the recent development of indole dimers and hybrids with a potential activity against MRSA, covering articles published between 2010 and 2020. The structure-activity relationship and the mechanism of action are also discussed to facilitate further rational design of more effective candidates.
Collapse
Affiliation(s)
- Tingting Meng
- Medical College, Xi'an Peihua University, Xi'an, Shaanxi, China
| | - Yani Hou
- Medical College, Xi'an Peihua University, Xi'an, Shaanxi, China
| | - Congshan Shang
- Medical College, Xi'an Peihua University, Xi'an, Shaanxi, China
| | - Jing Zhang
- School of Biomedical and Food Engineering, Shangluo University, Shangluo, Shaanxi, China
| | - Bo Zhang
- School of Biomedical and Food Engineering, Shangluo University, Shangluo, Shaanxi, China
| |
Collapse
|
23
|
Song F, Li Z, Bian Y, Huo X, Fang J, Shao L, Zhou M. Indole/isatin-containing hybrids as potential antibacterial agents. Arch Pharm (Weinheim) 2020; 353:e2000143. [PMID: 32667714 DOI: 10.1002/ardp.202000143] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2020] [Revised: 06/18/2020] [Accepted: 06/22/2020] [Indexed: 12/11/2022]
Abstract
The emergence and worldwide spread of drug-resistant bacteria have already posed a serious threat to human life, creating the urgent need to develop potent and novel antibacterial drug candidates with high efficacy. Indole and isatin (indole-2,3-dione) present a wide structural and mechanistic diversity, so their derivatives possess various pharmacological properties and occupy a salient place in the development of new drugs. Indole/isatin-containing hybrids, which demonstrate a promising activity against a panel of clinically important Gram-positive and Gram-negative bacteria, are privileged scaffolds for the discovery of novel antibacterial candidates. This review, covering articles published between January 2015 and May 2020, focuses on the development and structure-activity relationship (SAR) of indole/isatin-containing hybrids with potential application for fighting bacterial infections, to facilitate further rational design of novel drug candidates.
Collapse
Affiliation(s)
- Feng Song
- Shandong Key Laboratory of Biophysics, Institute of Biophysics, Dezhou University, Dezhou, Shandong, China.,School of Life Sciences, Dezhou University, Dezhou, Shandong, China
| | - Zhenghua Li
- Shandong Key Laboratory of Biophysics, Institute of Biophysics, Dezhou University, Dezhou, Shandong, China
| | - Yunqiang Bian
- Shandong Key Laboratory of Biophysics, Institute of Biophysics, Dezhou University, Dezhou, Shandong, China
| | - Xiankai Huo
- Department of Medical Imaging, Dezhou People's Hospital, Dezhou, Shandong, China
| | - Junman Fang
- School of Life Sciences, Dezhou University, Dezhou, Shandong, China
| | - Linlin Shao
- School of Life Sciences, Dezhou University, Dezhou, Shandong, China
| | - Meng Zhou
- School of Life Sciences, Dezhou University, Dezhou, Shandong, China
| |
Collapse
|
24
|
Salem MA, Ragab A, Askar AA, El-Khalafawy A, Makhlouf AH. One-pot synthesis and molecular docking of some new spiropyranindol-2-one derivatives as immunomodulatory agents and in vitro antimicrobial potential with DNA gyrase inhibitor. Eur J Med Chem 2020; 188:111977. [DOI: 10.1016/j.ejmech.2019.111977] [Citation(s) in RCA: 48] [Impact Index Per Article: 12.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2019] [Revised: 11/07/2019] [Accepted: 12/16/2019] [Indexed: 12/17/2022]
|
25
|
Zhang Y, Du H, Liu H, He Q, Xu Z. Isatin dimers and their biological activities. Arch Pharm (Weinheim) 2020; 353:e1900299. [DOI: 10.1002/ardp.201900299] [Citation(s) in RCA: 25] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2019] [Revised: 12/20/2019] [Accepted: 12/28/2019] [Indexed: 12/12/2022]
Affiliation(s)
- Ya‐Zhou Zhang
- Teaching and Research Office of Analytical Chemistry, School of Pharmaceutical SciencesGuizhou University of Traditional Chinese Medicine Guizhou China
| | - Hong‐Zhi Du
- Teaching and Research Office of Analytical Chemistry, School of Pharmaceutical SciencesGuizhou University of Traditional Chinese Medicine Guizhou China
| | - Hai‐Lin Liu
- Teaching and Research Office of Analytical Chemistry, School of Pharmaceutical SciencesGuizhou University of Traditional Chinese Medicine Guizhou China
| | - Qian‐Song He
- Teaching and Research Office of Analytical Chemistry, School of Pharmaceutical SciencesGuizhou University of Traditional Chinese Medicine Guizhou China
| | - Zhi Xu
- Teaching and Research Office of Analytical Chemistry, School of Pharmaceutical SciencesGuizhou University of Traditional Chinese Medicine Guizhou China
| |
Collapse
|
26
|
Jiang D, Zhang G. Ciprofloxacin/Gatifloxacin‐1,2,3‐triazole‐isatin Hybrids and Their
In Vitro
Anticancer Activity. J Heterocycl Chem 2019. [DOI: 10.1002/jhet.3684] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
Affiliation(s)
- Dan Jiang
- School of Nuclear Technology and Chemistry & BiologyHubei University of Science and Technology Xianning Hubei China
| | - Guifu Zhang
- School of Nuclear Technology and Chemistry & BiologyHubei University of Science and Technology Xianning Hubei China
| |
Collapse
|
27
|
Discovery of novel oxoindolin derivatives as atypical dual inhibitors for DNA Gyrase and FabH. Bioorg Chem 2019; 93:103309. [PMID: 31585266 DOI: 10.1016/j.bioorg.2019.103309] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2019] [Revised: 08/20/2019] [Accepted: 09/19/2019] [Indexed: 12/24/2022]
Abstract
The antibacterial agents and therapies today are facing serious problems such as drug resistance. Introducing dual inhibiting effect is a valid approach to solve this trouble and bring advantages including wide adaptability, favorable safety and superiority of combination. We started from potential DNA Gyrase inhibitory backbone isatin to develop oxoindolin derivatives as atypical dual Gyrase (major) and FabH (assistant) inhibitors via a two-round screening. Aiming at blocking both duplication (Gyrase) and survival (FabH), most of synthesized compounds indicated potency against Gyrase and some of them inferred favorable inhibitory effect on FabH. The top hit I18 suggested comparable Gyrase inhibitory activity (IC50 = 0.025 μM) and antibacterial effect with the positive control Novobiocin (IC50 = 0.040 μM). FabH inhibitory activity (IC50 = 5.20 μM) was also successfully introduced. Docking simulation hinted possible important interacted residues and binding patterns for both target proteins. Adequate Structure-Activity Relation discussions provide the future orientations of modification. With high potency, low initial toxicity and dual inhibiting strategy, advanced compounds with therapeutic methods will be developed for clinical application.
Collapse
|
28
|
Gao F, Ye L, Wang Y, Kong F, Zhao S, Xiao J, Huang G. Benzofuran-isatin hybrids and their in vitro anti-mycobacterial activities against multi-drug resistant Mycobacterium tuberculosis. Eur J Med Chem 2019; 183:111678. [PMID: 31525660 DOI: 10.1016/j.ejmech.2019.111678] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2018] [Revised: 06/01/2019] [Accepted: 09/03/2019] [Indexed: 10/26/2022]
Abstract
A series of benzofuran-isatin hybrids 6a-n and 7a-g linked by alkyl linkers were designed and synthesized. Among them, hybrids 6a-l and 7a-g were assessed for their in vitro anti-mycobacterial activities against two multi-drug resistant Mycobacterium tuberculosis (MDR-MTB) strains and the cytotoxicity towards CHO cells. The preliminary results indicated that all hybrids (MIC: 0.125-16 μg/mL) showed excellent activity against the tested MDR-MTB strains, and low cytotoxicity (CC50: 64->512 μg/mL) towards CHO cells. Among them, hybrid 7e (MIC: 0.125 and 0.25 μg/mL) was highly active against the tested two MDR-MTB strains, which was 8-16 folds better than ciprofloxacin (MIC: 1 and 4 μg/mL), ≥512 folds more potent than rifampicin (MIC: 64 and > 128 μg/mL) and isoniazid (MIC: >128 μg/mL), but it was less active than TAM16 (MIC: <0.06 μg/mL). Moreover, the hybrid 7e (CC50: 128 μg/mL) also showed low cytotoxicity towards CHO cells, and high selectivity index (1,024). However, the metabolic stability and in vivo pharmacokinetic profiles of hybrid 7e were inferior to TAM16, so it still needs to be modified so as to get the optimized hybrid for potential use in mycobacterial treatment.
Collapse
Affiliation(s)
- Feng Gao
- State Key Laboratory of Biobased Material and Green Papermaking (LBMP), Qilu University of Technology (Shandong Academy of Sciences), Jinan, PR China; Department of Medical Imaging, Jinling Hospital, Medical School of Nanjing University, Nanjing, PR China; Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, PR China.
| | - Lei Ye
- State Key Laboratory of Biobased Material and Green Papermaking (LBMP), Qilu University of Technology (Shandong Academy of Sciences), Jinan, PR China
| | - Yabin Wang
- State Key Laboratory of Biobased Material and Green Papermaking (LBMP), Qilu University of Technology (Shandong Academy of Sciences), Jinan, PR China
| | - Fangong Kong
- State Key Laboratory of Biobased Material and Green Papermaking (LBMP), Qilu University of Technology (Shandong Academy of Sciences), Jinan, PR China
| | - Shijia Zhao
- Wuhan University of Science and Technology, Wuhan, Hubei, PR China
| | - Jiaqi Xiao
- State Key Laboratory of Biobased Material and Green Papermaking (LBMP), Qilu University of Technology (Shandong Academy of Sciences), Jinan, PR China; Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, PR China.
| | - Gang Huang
- Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, PR China.
| |
Collapse
|
29
|
Ding Z, Hou P, Liu B. Gatifloxacin‐1,2,3‐triazole‐isatin hybrids and their antimycobacterial activities. Arch Pharm (Weinheim) 2019; 352:e1900135. [PMID: 31441087 DOI: 10.1002/ardp.201900135] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2019] [Revised: 07/18/2019] [Accepted: 07/23/2019] [Indexed: 11/09/2022]
Affiliation(s)
- Zhen Ding
- Department of PharmacyBozhou People's Hospital Bozhou China
| | - Panfei Hou
- Department of Clinical LaboratoryLianshui County People's Hospital Lianshui China
| | - Bi Liu
- School of Nuclear Technology and Chemistry and BiologyHubei University of Science and Technology Xianning China
| |
Collapse
|
30
|
Chen R, Zhang H, Ma T, Xue H, Miao Z, Chen L, Shi X. Moxifloxacin/Gatifloxacin‐1,2,3‐triazole‐isatin Hybrids with Hydrogen‐Bond Donor and Their
In Vitro
Anticancer Activity. J Heterocycl Chem 2019. [DOI: 10.1002/jhet.3670] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Affiliation(s)
- Rongxing Chen
- Xuzhou Women & Children's Healthcare Hospital Xuzhou Jiangsu 221009 People's Republic of China
| | - Hao Zhang
- Department of NeurosurgeryXuzhou Central Hospital Second Division Xuzhou Jiangsu 221009 People's Republic of China
| | - Tianwei Ma
- Xuzhou Women & Children's Healthcare Hospital Xuzhou Jiangsu 221009 People's Republic of China
| | - Huarui Xue
- Xuzhou Women & Children's Healthcare Hospital Xuzhou Jiangsu 221009 People's Republic of China
| | - Zhong Miao
- Xuzhou Women & Children's Healthcare Hospital Xuzhou Jiangsu 221009 People's Republic of China
| | - Liyan Chen
- Xuzhou Women & Children's Healthcare Hospital Xuzhou Jiangsu 221009 People's Republic of China
| | - Xiangkui Shi
- Xuzhou Women & Children's Healthcare Hospital Xuzhou Jiangsu 221009 People's Republic of China
| |
Collapse
|
31
|
Singh A, Singh JV, Rana A, Bhagat K, Gulati HK, Kumar R, Salwan R, Bhagat K, Kaur G, Singh N, Kumar R, Singh H, Sharma S, Bedi PMS. Monocarbonyl Curcumin-Based Molecular Hybrids as Potent Antibacterial Agents. ACS OMEGA 2019; 4:11673-11684. [PMID: 31460274 PMCID: PMC6682034 DOI: 10.1021/acsomega.9b01109] [Citation(s) in RCA: 47] [Impact Index Per Article: 9.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/17/2019] [Accepted: 06/14/2019] [Indexed: 05/22/2023]
Abstract
Keeping in view various pharmacological attributes of curcumin, coumarin, and isatin derivatives, triazole-tethered monocarbonyl curcumin-coumarin and curcumin-isatin molecular hybrids have been synthesized and evaluated for their antibacterial potential against Gram-positive (Enterococcus faecalis and Staphylococcus aureus) and Gram-negative (Pseudomonas aeruginosa and Escherichia coli) human pathogenic bacterial strains. Among all hybrid molecules, A-4 and B-38 showed the most potent antibacterial activity with inhibition zones of 29 and 31 mm along with MIC values of 12.50 and 6.25 μg/mL, respectively. Structure-activity relationship that emerged from biological data revealed that the two-carbon alkyl chain between triazole and coumarin/isatin moiety is well tolerable for the activity. Bromo substitution at the fifth position of isatin, para-cholo substitution in the case of curcumin-isatin, and para-methoxy in the case of curcumin-coumarin hybrids on ring A of curcumin are most suitable groups for the antibacterial activity. Various types of binding interactions of A-4 and B-38 within the active site of dihydrofolate reductase (DHFR) of S. aureus are also streamlined by molecular modeling studies, suggesting their capability in completely blocking DHFR.
Collapse
Affiliation(s)
- Atamjit Singh
- Department of Pharmaceutical
Sciences, Guru Nanak Dev University, Amritsar, Punjab 143005, India
| | - Jatinder Vir Singh
- Department of Pharmaceutical
Sciences, Guru Nanak Dev University, Amritsar, Punjab 143005, India
| | - Abhineet Rana
- EMC Group
of Hospital, Green Avenue, Amritsar, Punjab 143001, India
| | - Kavita Bhagat
- Department of Pharmaceutical
Sciences, Guru Nanak Dev University, Amritsar, Punjab 143005, India
| | - Harmandeep Kaur Gulati
- Department of Pharmaceutical
Sciences, Guru Nanak Dev University, Amritsar, Punjab 143005, India
| | - Raman Kumar
- Department of Pharmaceutical
Sciences, Guru Nanak Dev University, Amritsar, Punjab 143005, India
| | - Rajan Salwan
- Department of Pharmaceutical
Sciences, Guru Nanak Dev University, Amritsar, Punjab 143005, India
| | - Kajal Bhagat
- Department of Pharmaceutical
Sciences, Guru Nanak Dev University, Amritsar, Punjab 143005, India
| | - Gurinder Kaur
- Department of Pharmaceutical
Sciences, Guru Nanak Dev University, Amritsar, Punjab 143005, India
| | - Navjot Singh
- Department of Pharmaceutical
Sciences, Guru Nanak Dev University, Amritsar, Punjab 143005, India
| | - Randeep Kumar
- Department of Pharmaceutical
Sciences, Guru Nanak Dev University, Amritsar, Punjab 143005, India
| | - Harbinder Singh
- Department of Pharmaceutical
Sciences, Guru Nanak Dev University, Amritsar, Punjab 143005, India
- E-mail: (H.S.)
| | - Sahil Sharma
- Department of Pharmaceutical
Sciences, Guru Nanak Dev University, Amritsar, Punjab 143005, India
- E-mail: (S.S.)
| | - Preet Mohinder Singh Bedi
- Department of Pharmaceutical
Sciences, Guru Nanak Dev University, Amritsar, Punjab 143005, India
- E-mail: (P.M.S.B.)
| |
Collapse
|
32
|
Gao F, Ye L, Kong F, Huang G, Xiao J. Design, synthesis and antibacterial activity evaluation of moxifloxacin-amide-1,2,3-triazole-isatin hybrids. Bioorg Chem 2019; 91:103162. [PMID: 31382058 DOI: 10.1016/j.bioorg.2019.103162] [Citation(s) in RCA: 29] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2019] [Revised: 07/24/2019] [Accepted: 07/27/2019] [Indexed: 11/30/2022]
Abstract
In this work, a series of novel moxifloxacin-amide-1,2,3-triazole-isatin hybrids 7a-l were designed and synthesized. The in vitro antibacterial activity against a panel of clinically important Gram-positive and Gram-negative bacteria including drug-resistant pathogens was also evaluated. All hybrids showed considerable activity against the tested pathogens with MIC values of ≤0.03 to 128 μg/mL, and some of them such as hybrids 7e, 7g and 7j were comparable to or better than the parent moxifloxacin (MIC: ≤0.03-8 μg/mL). Moreover, hybrids 7e, 7g and 7j also demonstrated low cytotoxicity towards CHO cells. However, the in vivo pharmacokinetic profiles of these three hybrids were generally far inferior to the parent moxifloxacin. The structure-activity relationship and structure-cytotoxicity relationship were also studied and discussed which may help with the identification of new chemical entities as potent antibacterial agents.
Collapse
Affiliation(s)
- Feng Gao
- State Key Laboratory of Biobased Material and Green Papermaking (LBMP), Qilu University of Technology (Shandong Academy of Sciences), Jinan, PR China; Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, PR China
| | - Lei Ye
- State Key Laboratory of Biobased Material and Green Papermaking (LBMP), Qilu University of Technology (Shandong Academy of Sciences), Jinan, PR China
| | - Fangong Kong
- State Key Laboratory of Biobased Material and Green Papermaking (LBMP), Qilu University of Technology (Shandong Academy of Sciences), Jinan, PR China
| | - Gang Huang
- Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, PR China.
| | - Jiaqi Xiao
- State Key Laboratory of Biobased Material and Green Papermaking (LBMP), Qilu University of Technology (Shandong Academy of Sciences), Jinan, PR China; Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, PR China.
| |
Collapse
|
33
|
Wang R, Xu K, Shi W. Quinolone derivatives: Potential anti‐HIV agent—development and application. Arch Pharm (Weinheim) 2019; 352:e1900045. [DOI: 10.1002/ardp.201900045] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2019] [Revised: 04/28/2019] [Accepted: 05/01/2019] [Indexed: 01/03/2023]
Affiliation(s)
- Ruo Wang
- College of ChemistryFuzhou University Fuzhou Fujian People's Republic of China
| | - Kai Xu
- College of ChemistryFuzhou University Fuzhou Fujian People's Republic of China
| | - Weixiong Shi
- College of ChemistryFuzhou University Fuzhou Fujian People's Republic of China
| |
Collapse
|
34
|
Guo Y, Xu T, Bao C, Liu Z, Fan J, Yang R, Qin S. Design and synthesis of new norfloxacin-1,3,4-oxadiazole hybrids as antibacterial agents against methicillin-resistant Staphylococcus aureus (MRSA). Eur J Pharm Sci 2019; 136:104966. [PMID: 31233865 DOI: 10.1016/j.ejps.2019.104966] [Citation(s) in RCA: 38] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2019] [Revised: 05/27/2019] [Accepted: 06/20/2019] [Indexed: 01/09/2023]
Abstract
Toward the search of new antibacterial agents to control methicillin-resistant Staphylococcus aureus (MRSA), a class of new norfloxacin-1,3,4-oxadiazole hybrids were designed and synthesized. Antibacterial activities against drug-sensitive bacteria S. aureus and clinical drug resistant isolates of MRSA were evaluated. Compound 5k exhibited excellent antibacterial activities against S. aureus (MIC: 2 μg/mL) and MRSA1-3 (MIC: 0.25-1 μg/mL). The time-kill kinetics demonstrated that compound 5k had an advantage over commonly used antibiotics vancomycin in killing S. aureus and MRSA. Moreover, compound 5k could inhibit the bacteria and destroy their membranes in a short time, and showed very low cytotoxicity to NRK-52E cells. Some interesting structure-activity relationships (SARs) were also discussed. These results indicated that these norfloxacin-1,3,4-oxadiazole hybrids could be further developed into new antibacterial agents against MRSA.
Collapse
Affiliation(s)
- Yong Guo
- Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, School of Pharmaceutical Sciences, Zhengzhou University, No. 100, KeXue Avenue, Zhengzhou 450001, Henan Province, PR China.
| | - Ting Xu
- Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, School of Pharmaceutical Sciences, Zhengzhou University, No. 100, KeXue Avenue, Zhengzhou 450001, Henan Province, PR China
| | - Chongnan Bao
- Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, School of Pharmaceutical Sciences, Zhengzhou University, No. 100, KeXue Avenue, Zhengzhou 450001, Henan Province, PR China
| | - Zhiyan Liu
- Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, School of Pharmaceutical Sciences, Zhengzhou University, No. 100, KeXue Avenue, Zhengzhou 450001, Henan Province, PR China
| | - Jiangping Fan
- Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, School of Pharmaceutical Sciences, Zhengzhou University, No. 100, KeXue Avenue, Zhengzhou 450001, Henan Province, PR China
| | - Ruige Yang
- Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, School of Pharmaceutical Sciences, Zhengzhou University, No. 100, KeXue Avenue, Zhengzhou 450001, Henan Province, PR China.
| | - Shangshang Qin
- Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, School of Pharmaceutical Sciences, Zhengzhou University, No. 100, KeXue Avenue, Zhengzhou 450001, Henan Province, PR China.
| |
Collapse
|
35
|
Bhagat K, Bhagat J, Gupta MK, Singh JV, Gulati HK, Singh A, Kaur K, Kaur G, Sharma S, Rana A, Singh H, Sharma S, Singh Bedi PM. Design, Synthesis, Antimicrobial Evaluation, and Molecular Modeling Studies of Novel Indolinedione-Coumarin Molecular Hybrids. ACS OMEGA 2019; 4:8720-8730. [PMID: 31459961 PMCID: PMC6648594 DOI: 10.1021/acsomega.8b02481] [Citation(s) in RCA: 64] [Impact Index Per Article: 12.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/22/2018] [Accepted: 01/03/2019] [Indexed: 05/14/2023]
Abstract
Keeping in view various pharmacological attributes of indole and coumarin derivatives, a new series of indolindione-coumarin molecular hybrids was rationally designed and synthesized. All synthesized hybrid molecules were evaluated for their antimicrobial potential against Gram-negative bacterial strains (Escherichia coli and Salmonella enterica), Gram-positive bacterial strains (Staphylococcus aureus and Mycobacterium smegmatis), and four fungal strains (Candida albicans, Alternaria mali, Penicillium sp., and Fusarium oxysporum) by using the agar gel diffusion method. Among all synthetics, compounds K-1 and K-2 were found to be the best antimicrobial agents with the minimum inhibitory concentration values of 30 and 312 μg/mL, against Penicillium sp. and S. aureus, respectively. The biological data revealed some interesting facts about the structure-activity relationship which state that the electronic environment on the indolinedione moiety and carbon chain length between indolinedione and triazole moieties considerably affect the antimicrobial potential of the synthesized hybrids. Various types of binding interactions of K-2 within the active site of S. aureus dihydrofolate reductase were also streamlined by molecular modeling studies, which revealed the possible mechanism for potent antibacterial activity of the compound.
Collapse
Affiliation(s)
- Kavita Bhagat
- Department
of Pharmaceutical Sciences and Department of Microbiology, Guru Nanak Dev University, Amritsar, Punjab 143005, India
| | - Jyoti Bhagat
- Department
of Pharmaceutical Sciences and Department of Microbiology, Guru Nanak Dev University, Amritsar, Punjab 143005, India
| | - Manish Kumar Gupta
- TERI-Deakin Nanobiotechnology Centre, The Energy and Resources Institute, TERI Gram, Gual Pahari, Gurugram, Haryana 122001, India
| | - Jatinder Vir Singh
- Department
of Pharmaceutical Sciences and Department of Microbiology, Guru Nanak Dev University, Amritsar, Punjab 143005, India
| | - Harmandeep Kaur Gulati
- Department
of Pharmaceutical Sciences and Department of Microbiology, Guru Nanak Dev University, Amritsar, Punjab 143005, India
| | - Atamjit Singh
- Department
of Pharmaceutical Sciences and Department of Microbiology, Guru Nanak Dev University, Amritsar, Punjab 143005, India
| | - Kamalpreet Kaur
- Department
of Pharmaceutical Sciences and Department of Microbiology, Guru Nanak Dev University, Amritsar, Punjab 143005, India
| | - Gurinder Kaur
- Department
of Pharmaceutical Sciences and Department of Microbiology, Guru Nanak Dev University, Amritsar, Punjab 143005, India
| | - Shally Sharma
- Department
of Pharmaceutical Sciences and Department of Microbiology, Guru Nanak Dev University, Amritsar, Punjab 143005, India
| | - Abhineet Rana
- EMC Group of Hospital, Green Avenue, Amritsar, Punjab 143001, India
| | - Harbinder Singh
- Department
of Pharmaceutical Sciences and Department of Microbiology, Guru Nanak Dev University, Amritsar, Punjab 143005, India
- E-mail: . Phone: +919463148367 (H.S.)
| | - Sahil Sharma
- Department
of Pharmaceutical Sciences and Department of Microbiology, Guru Nanak Dev University, Amritsar, Punjab 143005, India
- E-mail: (S.S.)
| | - Preet Mohinder Singh Bedi
- Department
of Pharmaceutical Sciences and Department of Microbiology, Guru Nanak Dev University, Amritsar, Punjab 143005, India
- E-mail: . Phone: +919815698249 (P.M.S.B.)
| |
Collapse
|
36
|
Zhang B. Quinolone derivatives and their antifungal activities: An overview. Arch Pharm (Weinheim) 2019; 352:e1800382. [PMID: 31021468 DOI: 10.1002/ardp.201800382] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2018] [Revised: 01/29/2019] [Accepted: 02/03/2019] [Indexed: 11/06/2022]
Abstract
More than 300 million people suffer from the incidence of life-threatening invasive fungal infections, resulting in over 1.35 million deaths annually. Currently, the antifungal agents available in clinics are rather limited, and the rapid development of resistance to the existing antifungal drugs has further aggravated mortality. Quinolones possess a broad spectrum of chemotherapeutic properties and demonstrate considerable antifungal activities as well. Various quinolone derivatives have been screened for their antifungal activities, and some of them exhibit excellent potency against both drug-susceptible and drug-resistant fungi. This review aims to outline the recent advances in quinolone derivatives as potential antifungal agents and summarize the structure-activity relationship, to provide insights for the rational design of more active candidates.
Collapse
Affiliation(s)
- Bo Zhang
- School of Chemistry and Life Science, Anshan Normal University, Anshan, Liaoning, P.R. China
| |
Collapse
|
37
|
Gao F, Wang T, Gao M, Zhang X, Liu Z, Zhao S, Lv Z, Xiao J. Benzofuran-isatin-imine hybrids tethered via different length alkyl linkers: Design, synthesis and in vitro evaluation of anti-tubercular and anti-bacterial activities as well as cytotoxicity. Eur J Med Chem 2019; 165:323-331. [DOI: 10.1016/j.ejmech.2019.01.042] [Citation(s) in RCA: 29] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2018] [Revised: 01/16/2019] [Accepted: 01/17/2019] [Indexed: 10/27/2022]
|
38
|
Isatin derivatives and their anti-bacterial activities. Eur J Med Chem 2019; 164:678-688. [DOI: 10.1016/j.ejmech.2018.12.017] [Citation(s) in RCA: 92] [Impact Index Per Article: 18.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2018] [Revised: 12/06/2018] [Accepted: 12/08/2018] [Indexed: 12/16/2022]
|
39
|
Triazole derivatives and their antiplasmodial and antimalarial activities. Eur J Med Chem 2019; 166:206-223. [PMID: 30711831 DOI: 10.1016/j.ejmech.2019.01.047] [Citation(s) in RCA: 141] [Impact Index Per Article: 28.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2019] [Revised: 01/19/2019] [Accepted: 01/19/2019] [Indexed: 01/23/2023]
Abstract
Malaria, caused by protozoan parasites of the genus Plasmodium especially by the most prevalent parasite Plasmodium falciparum, represents one of the most devastating and common infectious disease globally. Nearly half of the world population is under the risk of being infected, and more than 200 million new clinical cases with around half a million deaths occur annually. Drug therapy is the mainstay of antimalarial therapy, yet current drugs are threatened by the development of resistance, so it's imperative to develop new antimalarials with great potency against both drug-susceptible and drug-resistant malaria. Triazoles, bearing a five-membered heterocyclic ring with three nitrogen atoms, exhibit promising in vitro antiplasmodial and in vivo antimalarial activities. Moreover, several triazole-based drugs have already used in clinics for the treatment of various diseases, demonstrating the excellent pharmaceutical profiles. Therefore, triazole derivatives have the potential for clinical deployment in the control and eradication of malaria. This review covers the recent advances of triazole derivatives especially triazole hybrids as potential antimalarials. The structure-activity relationship is also discussed to provide an insight for rational designs of more efficient antimalarial candidates.
Collapse
|
40
|
Xu Z, Zhao SJ, Lv ZS, Gao F, Wang Y, Zhang F, Bai L, Deng JL. Fluoroquinolone-isatin hybrids and their biological activities. Eur J Med Chem 2018; 162:396-406. [PMID: 30453247 DOI: 10.1016/j.ejmech.2018.11.032] [Citation(s) in RCA: 81] [Impact Index Per Article: 13.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2018] [Revised: 11/04/2018] [Accepted: 11/10/2018] [Indexed: 12/20/2022]
Abstract
Hybridization of different pharmacophores from various bioactive substances into a single molecule is the potential weapon to prevent the drug resistance since this strategy can provide new leads with complimentary activities and/or multiple pharmacological targets. Fluoroquinolone and isatin are common pharmacophores, and their derivatives possess various biological activities. Obviously, hybridization of these two pharmacophores into one molecule may result in novel candidates with broader spectrum, higher efficiency, lower toxicity as well as multiple mechanisms of action. Therefore, fluoroquinolone-isatin hybrids have the potential for clinical deployment in the control and eradication of various diseases. This review covers the recent advances of fluoroquinolone-isatin hybrids as potential anti-bacterial, anti-tubercular, anti-viral and anti-cancer agents. The structure-activity relationship is also discussed to pave the way for the further rational development of this kind of hybrids.
Collapse
Affiliation(s)
- Zhi Xu
- Huanghuai University, College of Chemistry and Pharmaceutical Engineering, Zhumadian, PR China.
| | - Shi-Jia Zhao
- Key Laboratory of Hubei Province for Coal Conversion and New Carbon Materials, Wuhan University of Science and Technology, Wuhan, PR China
| | - Zao-Sheng Lv
- Key Laboratory of Hubei Province for Coal Conversion and New Carbon Materials, Wuhan University of Science and Technology, Wuhan, PR China
| | - Feng Gao
- Academy of Advanced Interdisciplinary Studies, Qilu University of Technology (Shandong Academy of Sciences), Jinan, Shandong, 250353, PR China
| | - Yinling Wang
- Huanghuai University, College of Chemistry and Pharmaceutical Engineering, Zhumadian, PR China
| | - Feng Zhang
- Huanghuai University, College of Chemistry and Pharmaceutical Engineering, Zhumadian, PR China
| | - Liuyang Bai
- Huanghuai University, College of Chemistry and Pharmaceutical Engineering, Zhumadian, PR China
| | | |
Collapse
|
41
|
Gao F, Wang P, Yang H, Miao Q, Ma L, Lu G. Recent developments of quinolone-based derivatives and their activities against Escherichia coli. Eur J Med Chem 2018; 157:1223-1248. [DOI: 10.1016/j.ejmech.2018.08.095] [Citation(s) in RCA: 66] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2018] [Revised: 08/29/2018] [Accepted: 08/31/2018] [Indexed: 12/14/2022]
|